Advertisement

Antibiotics and the Intestinal Microbiome: Individual Responses, Resilience of the Ecosystem, and the Susceptibility to Infections

  • Sophie Thiemann
  • Nathiana Smit
  • Till StrowigEmail author
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 398)

Abstract

The intestinal microbiota is a diverse ecosystem containing thousands of microbial species, whose metabolic activity affects many aspects of human physiology. Large-scale surveys have demonstrated that an individual’s microbiota composition is shaped by factors such as diet and the use of medications, including antibiotics. Loss of overall diversity and in some cases loss of single groups of bacteria as a consequence of antibiotic treatment in humans has been associated with enhanced susceptibility toward gastrointestinal infections and with enhanced weight gain and obesity in young children. Moreover, the extensive use of antibiotics has led to an increased abundance of antibiotic resistance genes (ARGs) within commensal bacteria that can be transferred to invading pathogens, which complicates the treatment of bacterial infections. In this review, we provide insight into the complex interplay between the microbiota and antibiotics focussing on (i) the effect of antibiotics on the composition of the microbiota, (ii) the impact of antibiotics on gastrointestinal infections, and (iii) finally the role of the microbiota as reservoir for ARGs. We also discuss how targeted manipulation of the microbiota may be used as an innovative therapeutic approach to reduce the incidence of bacterial infections as well as resulting complications.

Keywords

Horizontal Gene Transfer Clostridium Difficile Infection Intestinal Microbiota Mucus Layer Commensal Bacterium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Aarestrup FM, Seyfarth AM, Emborg HD et al (2001) Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob Agents Chemother 45:2054–2059Google Scholar
  2. Accountability NUSG (2011) Antibiotic resistanste: agencies have made limited progress addressing antibiotic use in animalsGoogle Scholar
  3. Aloisio I, Mazzola G, Corvaglia LT et al (2014) Influence of intrapartum antibiotic prophylaxis against group B Streptococcus on the early newborn gut composition and evaluation of the anti-Streptococcus activity of Bifidobacterium strains. Appl Microbiol Biotechnol 98:6051–6060Google Scholar
  4. Aminov RI (2010) A brief history of the antibiotic era: lessons learned and challenges for the future. Front Microbiol 1:134Google Scholar
  5. Aminov RI (2011) Horizontal gene exchange in environmental microbiota. Front Microbiol 2:158Google Scholar
  6. Archbald-Pannone LR, Boone JH, Carman RJ et al (2014) Clostridium difficile ribotype 027 is most prevalent among inpatients admitted from long-term care facilities. J Hosp Infect 88:218–221Google Scholar
  7. Arutyunov D, Frost LS (2013) F conjugation: back to the beginning. Plasmid 70:18–32Google Scholar
  8. Bertrand S, Weill F-X, Cloeckaert A et al (2006) Clonal emergence of extended-spectrum beta-lactamase (CTX-M-2)-producing Salmonella enterica serovar Virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003). J Clin Microbiol 44:2897–2903Google Scholar
  9. Best EL, Freeman J, Wilcox MH (2012) Models for the study of Clostridium difficile infection. Gut Microbes 3:145–167Google Scholar
  10. Bohnhoff M, Miller CP (1962) Enhanced susceptibility to Salmonella infection in streptomycin-treated mice. J Infect Dis 111:117–127Google Scholar
  11. Brandl K, Plitas G, Mihu CN et al (2008) Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455:804–807Google Scholar
  12. Brandt LJ, Aroniadis OC, Mellow M et al (2012) Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 107:1079–1087Google Scholar
  13. Broaders E, Gahan CGM, Marchesi JR (2013) Mobile genetic elements of the human gastrointestinal tract: potential for spread of antibiotic resistance genes. Gut Microbes 4:271–280Google Scholar
  14. Buffie CG, Pamer EG (2013) Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 13:790–801Google Scholar
  15. Buffie CG, Jarchum I, Equinda M et al (2012) Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun 80:62–73Google Scholar
  16. Buffie CG, Bucci V, Stein RR et al (2015) Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517:205–208Google Scholar
  17. Bulgarelli D, Schlaeppi K, Spaepen S et al (2013) Structure and functions of the bacterial microbiota of plants. Annu Rev Plant Biol 64:807–838Google Scholar
  18. Bushman FD, Minot S, Sinha R et al (2011) The human gut virome: inter-individual variation and dynamic response to diet. Genome Res 21:1616–1625Google Scholar
  19. Caballero S, Carter R, Ke X et al (2015) Distinct but spatially overlapping intestinal niches for vancomycin-resistant Enterococcus faecium and carbapenem-resistant Klebsiella pneumoniae. PLoS Pathog 11:e1005132Google Scholar
  20. Cabello FC (2006) Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment. Environ Microbiol 8:1137–1144Google Scholar
  21. Chandler MS (1992) The gene encoding cAMP receptor protein is required for competence development in Haemophilus influenzae Rd. Proc Natl Acad Sci USA 89:1626–1630Google Scholar
  22. Chen X, Katchar K, Goldsmith JD et al (2008) A mouse model of Clostridium difficile-associated disease. Gastroenterology 135:1984–1992Google Scholar
  23. Choi K-H, Kim K-J (2009) Applications of transposon-based gene delivery system in bacteria. J Microbiol Biotechnol 19:217–228Google Scholar
  24. Claesson MJ, Jeffery IB, Conde S et al (2012) Gut microbiota composition correlates with diet and health in the elderly. Nature 488:178–184Google Scholar
  25. Clemente JC, Pehrsson EC, Blaser MJ et al (2015) The microbiome of uncontacted Amerindians. Sci Adv 1:e1500183–e1500183Google Scholar
  26. Cohen SH, Gerding DN, Johnson S et al (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31:431–455Google Scholar
  27. Conlan S, Thomas PJ, Deming C, et al (2014) Single-molecule sequencing to track plasmid diversity of hospital-associated carbapenemase-producing Enterobacteriaceae. Sci Transl Med 6:254ra126–254ra126. doi: 10.1126/scitranslmed.3009845
  28. Cox LM, Blaser MJ (2015) Antibiotics in early life and obesity. Nat Rev Endocrinol 11:182–190Google Scholar
  29. Cua DJ, Tato CM (2010) Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10:479–489Google Scholar
  30. D’Costa VM, King CE, Kalan L et al (2011) Antibiotic resistance is ancient. Nature 477:457–461Google Scholar
  31. de Boer P, Wagenaar JA, Achterberg RP et al (2002) Generation of Campylobacter jejuni genetic diversity in vivo. Mol Microbiol 44:351–359Google Scholar
  32. De La Cochetière MF, Durand T, Lepage P et al (2005) Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol 43:5588–5592Google Scholar
  33. Dethlefsen L, Relman DA (2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 108 Suppl 1:4554–4561Google Scholar
  34. Dethlefsen L, Huse S, Sogin ML, Relman DA (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6:e280Google Scholar
  35. Dobrindt U, Chowdary MG, Krumbholz G, Hacker J (2010) Genome dynamics and its impact on evolution of Escherichia coli. Med Microbiol Immunol 199:145–154Google Scholar
  36. Doron S, Hibberd PL, Goldin B et al (2015) Effect of Lactobacillus rhamnosus GG administration on vancomycin-resistant Enterococcus colonization in adults with comorbidities. Antimicrob Agents Chemother 59:4593–4599Google Scholar
  37. Endtz HP, Ruijs GJ, van Klingeren B et al (1991) Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J Antimicrob Chemother 27:199–208Google Scholar
  38. Ferreira RBR, Gill N, Willing BP et al (2011) The intestinal microbiota plays a role in Salmonella-induced colitis independent of pathogen colonization. PLoS ONE 6:e20338Google Scholar
  39. Finkel SE, Kolter R (2001) DNA as a nutrient: novel role for bacterial competence gene homologs. J Bacteriol 183:6288–6293Google Scholar
  40. Fisher K, Phillips C (2009) The ecology, epidemiology and virulence of Enterococcus. Microbiology (Reading, Engl) 155:1749–1757Google Scholar
  41. Fleming A (2001) On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. 1929. World Health OrganizationGoogle Scholar
  42. Forsberg KJ, Reyes A, Wang B et al (2012) The shared antibiotic resistome of soil bacteria and human pathogens. Science 337:1107–1111Google Scholar
  43. Forslund K, Sunagawa S, Kultima JR et al (2013) Country-specific antibiotic use practices impact the human gut resistome. Genome Res 23:1163–1169Google Scholar
  44. Fouhy F, Guinane CM, Hussey S et al (2012) High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother 56:5811–5820Google Scholar
  45. Frye JG, Lindsey RL, Meinersmann RJ et al (2011) Related antimicrobial resistance genes detected in different bacterial species co-isolated from swine fecal samples. Foodborne Pathog Dis 8:663–679Google Scholar
  46. Garnier F, Taourit S, Glaser P et al (2000) Characterization of transposon Tn1549, conferring VanB-type resistance in Enterococcus spp. Microbiology (Reading, Engl) 146 (Pt 6):1481–1489Google Scholar
  47. Gevers D, Huys G, Swings J (2003) In vitro conjugal transfer of tetracycline resistance from Lactobacillus isolates to other Gram-positive bacteria. FEMS Microbiol Lett 225:125–130Google Scholar
  48. Ghosh TS, Gupta SS, Nair GB, Mande SS (2013) In silico analysis of antibiotic resistance genes in the gut microflora of individuals from diverse geographies and age-groups. PLoS ONE 8:e83823Google Scholar
  49. Gilmore MS, Clewell DB, Ike Y et al (2014) Enterococcus diversity, origins in nature, and gut colonization. Massachusetts Eye and Ear Infirmary, BostonGoogle Scholar
  50. Gorbach SL (2001) Antimicrobial use in animal feed—time to stop. N Engl J Med 345:1202–1203Google Scholar
  51. Gosalbes MJ, Valles Y, Jimenez-Hernandez N et al (2016) High frequencies of antibiotic resistance genes in infants’ meconium and early fecal samples. J Dev Orig Health Dis 7:35–44Google Scholar
  52. Goto Y, Obata T, Kunisawa J et al (2014) Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science 345:1254009–1254009Google Scholar
  53. Gough E, Shaikh H, Manges AR (2011) Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 53:994–1002Google Scholar
  54. Gueimonde M, Salminen S, Isolauri E (2006) Presence of specific antibiotic (tet) resistance genes in infant faecal microbiota. FEMS Immunol Med Microbiol 48:21–25Google Scholar
  55. Hachler H, Berger-bachi B, Kayser FH (1987) Genetic characterization of a Clostridium difficile erythromycin- clindamycin resistance determinant that is transferable to Staphylococcus aureus. Microbiology 31:1039–1045Google Scholar
  56. Hall IC, O’Toole E (1935) Intestinal flora in new-born infants: with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child 49:390–402Google Scholar
  57. Harrison E, Brockhurst MA (2012) Plasmid-mediated horizontal gene transfer is a coevolutionary process. Trends Microbiol 20:262–267Google Scholar
  58. Hasegawa M, Kamada N, Jiao Y et al (2012) Protective role of commensals against Clostridium difficile infection via an IL-1β-mediated positive-feedback loop. J Immunol 189:3085–3091Google Scholar
  59. Hecht G, Pothoulakis C, LaMont JT, Madara JL (1988) Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of cultured human intestinal epithelial monolayers. J Clin Invest 82:1516–1524Google Scholar
  60. Hentges DJ, Freter R (1962) In vivo and in vitro antagonism of intestinal bacteria against Shigella flexneri. I. Correlation between various tests. J Infect Dis 110:30–37Google Scholar
  61. Hidron AI, Edwards JR, Patel J et al (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 29:996–1011Google Scholar
  62. Howells CH, Joynson DH (1975) Possible role of animal feeding-stuffs in spread of antibiotic-resistant intestinal coliforms. 1:156–157Google Scholar
  63. Hu Y, Yang X, Qin J et al (2013) Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat Commun 4:2151Google Scholar
  64. Huddleston JR (2014) Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes. Infect Drug Resist 7:167–176Google Scholar
  65. Huddleston JR, Brokaw JM, Zak JC, Jeter RM (2013) Natural transformation as a mechanism of horizontal gene transfer among environmental Aeromonas species. Syst Appl Microbiol 36:224–234Google Scholar
  66. Hurd EA, Holmén JM, Hansson GC, Domino SE (2005) Gastrointestinal mucins of Fut2-null mice lack terminal fucosylation without affecting colonization by Candida albicans. Glycobiology 15:1002–1007Google Scholar
  67. Husain F, Veeranagouda Y, Boente R et al (2014) The Ellis Island Effect: A novel mobile element in a multi-drug resistant Bacteroides fragilis clinical isolate includes a mosaic of resistance genes from Gram-positive bacteria. Mobile Genetic Elements 4:e29801Google Scholar
  68. Ivanov II, Atarashi K, Manel N et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485–498Google Scholar
  69. Jarchum I, Liu M, Lipuma L, Pamer EG (2011) Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis. Infect Immun 79:1498–1503Google Scholar
  70. Jarchum I, Liu M, Shi C et al (2012) Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis. Infect Immun 80:2989–2996Google Scholar
  71. Jeffery IB, Lynch DB, O’Toole PW (2016) Composition and temporal stability of the gut microbiota in older persons. ISME J 10:170–182Google Scholar
  72. Jeon B, Muraoka W, Sahin O, Zhang Q (2008) Role of Cj1211 in natural transformation and transfer of antibiotic resistance determinants in Campylobacter jejuni. Antimicrob Agents Chemother 52:2699–2708Google Scholar
  73. Jernberg C, Löfmark S, Edlund C, Jansson JK (2007) Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 1:56–66Google Scholar
  74. Johansson MEV, Phillipson M, Petersson J, et al (2008) The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA 105:15064–15069Google Scholar
  75. Johansson MEV, Larsson JMH, Hansson GC (2011) The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci USA 108 Suppl 1:4659–4665Google Scholar
  76. Johansson MEV, Jakobsson HE, Holmén-Larsson J et al (2015) Normalization of host intestinal mucus layers requires long-term microbial colonization. Cell Host Microbe 18:582–592Google Scholar
  77. Johnning A, Kristiansson E, Angelin M et al (2015) Quinolone resistance mutations in the faecal microbiota of Swedish travellers to India. BMC Microbiol 15:235Google Scholar
  78. Just I, Richter HP, Prepens U et al (1994) Probing the action of Clostridium difficile toxin B in Xenopus laevis oocytes. J Cell Sci 107 (Pt 6):1653–1659Google Scholar
  79. Kelly CR, de Leon L, Jasutkar N (2012) Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. J Clin Gastroenterol 46:145–149Google Scholar
  80. Khanna S, Gupta A, Baddour LM, Pardi DS (2015) Epidemiology, outcomes, and predictors of mortality in hospitalized adults with Clostridium difficile infection. Intern Emerg Med 1–9Google Scholar
  81. Kinnebrew MA, Ubeda C, Zenewicz LA et al (2010) Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J Infect Dis 201:534–543Google Scholar
  82. Korpela K, Salonen A, Virta LJ et al (2016) Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat Commun 7:10410.0Google Scholar
  83. Landy J, Al-Hassi HO, McLaughlin SD et al (2011) Review article: faecal transplantation therapy for gastrointestinal disease. Aliment Pharmacol Ther 34:409–415Google Scholar
  84. Larentis DZ, Rosa RG, Santos Dos RP, Goldani LZ (2015) Outcomes and risk factors associated with Clostridium difficile diarrhea in hospitalized adult patients. Gastroenterol Res Pract 2015:346341–6Google Scholar
  85. Lau HY, Huffnagle GB, Moore TA (2008) Host and microbiota factors that control Klebsiella pneumoniae mucosal colonization in mice. Microbes Infect 10:1283–1290Google Scholar
  86. Lautenbach E, Marsicano R, Tolomeo P et al (2009) Epidemiology of antimicrobial resistance among gram-negative organisms recovered from patients in a multistate network of long-term care facilities. Infect Control Hosp Epidemiol 30:790–793Google Scholar
  87. Lawley TD, Clare S, Walker AW et al (2012) Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 8:e1002995Google Scholar
  88. Le Lay C, Dridi L, Bergeron MG et al (2016) Nisin is an effective inhibitor of Clostridium difficile vegetative cells and spore germination. J Med Microbiol 65:169–175Google Scholar
  89. Lessa FC, Mu Y, Bamberg WM et al (2015) Burden of Clostridium difficile infection in the United States. N Engl J Med 372:825–834Google Scholar
  90. Levy SB, FitzGerald GB, Macone AB (1976) Spread of antibiotic-resistant plasmids from chicken to chicken and from chicken to man. Nature 260:40–42Google Scholar
  91. Lewis BB, Buffie CG, Carter RA et al (2015) Loss of microbiota-mediated colonization resistance to Clostridium difficile infection with oral vancomycin compared with metronidazole. J Infect Dis jiv256Google Scholar
  92. Ley RE, Hamady M, Lozupone C et al (2008) Evolution of mammals and their gut microbes. Science 320:1647–1651. doi: 10.1126/science.1155725
  93. Li H, Limenitakis JP, Fuhrer T et al (2015) The outer mucus layer hosts a distinct intestinal microbial niche. Nat Commun 6:8292Google Scholar
  94. Loo VG, Poirier L, Miller MA et al (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353:2442–2449Google Scholar
  95. Lozupone CA, Stombaugh JI, Gordon JI et al (2012) Diversity, stability and resilience of the human gut microbiota. Nature 489:220–230Google Scholar
  96. Machado AMD, Sommer MOA (2014) Human intestinal cells modulate conjugational transfer of multidrug resistance plasmids between clinical Escherichia coli isolates. PLoS ONE 9:e100739–5Google Scholar
  97. Mathur S, Singh R (2005) Antibiotic resistance in food lactic acid bacteria—a review. Int J Food Microbiol 105:281–295Google Scholar
  98. Maurice CF, Haiser HJ, Turnbaugh PJ (2013) Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 152:39–50Google Scholar
  99. Michod RE, Wojciechowski MF, Hoelzer MA (1988) DNA repair and the evolution of transformation in the bacterium Bacillus subtilis. Genetics 118:31–39Google Scholar
  100. Milazzo I, Speciale A, Musumeci R et al (2006) Identification and antibiotic susceptibility of bacterial isolates from probiotic products available in Italy. New Microbiol 29:281–291. doi: 10.1016/S0168-1605(02)00162-9
  101. Mullany P, Pallen M, Wilks M et al (1996) A group II intron in a conjugative transposon from the gram-positive bacterium, Clostridium difficile. Gene 174:145–150Google Scholar
  102. Mullany P, Allan E, Roberts AP (2015) Mobile genetic elements in Clostridium difficile and their role in genome function. Res Microbiol 166:361–367Google Scholar
  103. Neuhauser MM, Weinstein RA, Rzdman R (2003) Antibiotic resistance among gram-negative bacilli in us intensive care units: implications for fluoroquinolone use. JAMA 289:885–888Google Scholar
  104. Niess JH, Brand S, Gu X et al (2005) CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307:254–258Google Scholar
  105. Nigro SJ, Holt KE, Pickard D, Hall RM (2015) Carbapenem and amikacin resistance on a large conjugative Acinetobacter baumannii plasmid. J Antimicrob Chemother 70:1259–1261Google Scholar
  106. Nordmann P, Naas T, Poirel L (2011) Global spread of carbapenemase-producing enterobacteriaceae. Emerging Infect Dis 17:1791–1798Google Scholar
  107. O’Connor JR, Johnson S, Gerding DN (2009) Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 136:1913–1924Google Scholar
  108. Oethinger M, Kern WV, Jellen-Ritter AS et al (2000) Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother 44:10–13Google Scholar
  109. Orenstein R, Dubberke E, Hardi R et al (2016) Safety and durability of RBX2660 (Microbiota Suspension) for recurrent Clostridium difficile infection: results of the PUNCH CD study. Clin Infect Dis 62:596–602Google Scholar
  110. Paltansing S, Vlot JA, Kraakman MEM et al (2013) Extended-spectrum β-lactamase-producing enterobacteriaceae among travelers from the Netherlands. Emerging Infect Dis 19:1206–1213Google Scholar
  111. Pantosti A, Del Grosso M, Tagliabue S et al (1999) Decrease of vancomycin-resistant enterococci in poultry meat after avoparcin ban. Lancet 354:741–742Google Scholar
  112. Paramsothy S, Borody TJ, Lin E et al (2015) Donor recruitment for fecal microbiota transplantation. Inflamm Bowel Dis 21:1600–1606Google Scholar
  113. Petersson J, Schreiber O, Hansson GC et al (2011) Importance and regulation of the colonic mucus barrier in a mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 300:G327–33Google Scholar
  114. Petrof EO, Gloor GB, Vanner SJ et al (2013) Stool substitute transplant therapy for the eradication of Clostridium difficile infection: “RePOOPulating” the gut. Microbiome 1:3Google Scholar
  115. Pham TAN, Clare S, Goulding D et al (2014) Epithelial IL-22RA1-mediated fucosylation promotes intestinal colonization resistance to an opportunistic pathogen. Cell Host Microbe 16:504–516Google Scholar
  116. Pickard JM, Maurice CF, Kinnebrew MA et al (2014) Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. Nature 514:638–641Google Scholar
  117. Pokharel BM, Koirala J, Dahal RK et al (2006) Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives. Int J Infect Dis 10:434–438Google Scholar
  118. Ramirez MS, Traglia GM, Lin DL et al (2014) Plasmid-mediated antibiotic resistance and virulence in gram-negatives: the Klebsiella pneumoniae paradigm. Microbiol Spectr 2:1–15Google Scholar
  119. Raymond F, Ouameur AA, Déraspe M et al (2016) The initial state of the human gut microbiome determines its reshaping by antibiotics. ISME J 10:707–720Google Scholar
  120. Redelings MD, Sorvillo F, Mascola L (2007) Increase in Clostridium difficile-related mortality rates, United States, 1999–2004. Emerging Infect Dis 13:1417–1419Google Scholar
  121. Reeves AE, Theriot CM, Bergin IL et al (2011) The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile infection. Gut Microbes 2:145–158Google Scholar
  122. Reeves AE, Koenigsknecht MJ, Bergin IL, Young VB (2012) Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae. Infect Immun 80:3786–3794Google Scholar
  123. Ruppe E, Armand-Lefevre L, Estellat C et al (2014) Acquisition of carbapenemase-producing enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013. Eurosurveillance 19:20768–4Google Scholar
  124. Rutten NBMM, Rijkers GT, Meijssen CB et al (2015) Intestinal microbiota composition after antibiotic treatment in early life: the INCA study. BMC Pediatr 15:204Google Scholar
  125. Saari A, Virta LJ, Sankilampi U et al (2015) Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life. Pediatrics 135:617–626Google Scholar
  126. Saleeby J, Ducea M, Clemens-Knott D (2003) Production and loss of high-density batholithic root, southern Sierra Nevada, California. Tectonics 22:n/a–n/aGoogle Scholar
  127. Salyers AA, Gupta A, Wang Y (2004) Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol 12:412–416Google Scholar
  128. Schmieger H, Schicklmaier P (1999) Transduction of multiple drug resistance of Salmonella enterica serovar typhimurium DT104. FEMS Microbiol Lett 170:251–256Google Scholar
  129. Searle LEJ, Best A, Nunez A et al (2009) A mixture containing galactooligosaccharide, produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar typhimurium infection in mice. J Med Microbiol 58:37–48Google Scholar
  130. Sebaihia M, Wren BW, Mullany P et al (2006) The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet 38:779–786Google Scholar
  131. Sekirov I, Tam NM, Jogova M et al (2008) Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun 76:4726–4736Google Scholar
  132. Sghir A, Gramet G, Suau A et al (2000) Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl Environ Microbiol 66:2263–2266Google Scholar
  133. Sievert DM, Ricks P, Edwards JR et al (2013) Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol 34:1–14Google Scholar
  134. Singh R, Schroeder CM, Meng J et al (2005) Identification of antimicrobial resistance and class 1 integrons in Shiga toxin-producing Escherichia coli recovered from humans and food animals. J Antimicrob Chemother 56:216–219Google Scholar
  135. Sommer MOA, Church GM, Dantas G et al (2009) Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 325:1128–1131Google Scholar
  136. Sorg JA, Sonenshein AL (2008) Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol 190:2505–2512Google Scholar
  137. Stecher B, Denzler R, Maier L et al (2012) Gut inflammation can boost horizontal gene transfer between pathogenic and commensal enterobacteriaceae. Proc Natl Acad Sci USA 109:1269–1274Google Scholar
  138. Talham GL, Jiang HQ, Bos NA, Cebra JJ (1999) Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system. Infect Immun 67:1992–2000Google Scholar
  139. Tanaka S, Kobayashi T, Songjinda P, et al (2009) Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol Med Microbiol 56:80–87Google Scholar
  140. Taylor DE, Chau AS (1997) Cloning and nucleotide sequence of the gyrA gene from Campylobacter fetus subsp. fetus ATCC 27374 and characterization of ciprofloxacin-resistant laboratory and clinical isolates. Antimicrob Agents Chemother 41:665–671Google Scholar
  141. Threlfall EJ (2000) Epidemic Salmonella Typhimurium DT 104—a truly international multiresistant clone. J Antimicrob Chemother 46:7–10Google Scholar
  142. Tolmasky ME, Chamorro RM, Crosa JH, Marini PM (1988) Transposon-Mediated Amikacin resistance in Klebsiella pneumoniae. Antimicrob Agents Chemother 32:1416–1420Google Scholar
  143. Tvede M, Rask-Madsen J (1989) Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1:1156–1160Google Scholar
  144. Ubeda C, Taur Y, Jenq RR et al (2010) Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 120:4332–4341Google Scholar
  145. Ubeda C, Bucci V, Caballero S et al (2013) Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun 81:965–973Google Scholar
  146. Uttley AH, Collins CH, Naidoo J, George RC (1988) Vancomycin-resistant enterococci. Lancet 1:57–58Google Scholar
  147. Vaishnava S, Behrendt CL, Ismail AS et al (2008) Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci USA 105:20858–20863Google Scholar
  148. Wani KA, Thakur MA, Fayaz AS et al (2009) Extended spectrum B-Lactamase mediated resistance in Escherichia coli in a tertiary care hospital. Int J Health Sci 3:155–163Google Scholar
  149. Webber MA, Piddock LJV (2003) The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 51:9–11Google Scholar
  150. Wenzel RP (2002) The antibiotic paradox: how the misuse of antibiotics destroys their curative powers (Book review), second edn. By Stuart B. Levy. 353 pp., illustrated. Cambridge, Mass., Perseus Publishing, 2002. $17.50. 0-7382-0440-4. N Engl J Med 347:1213–1213Google Scholar
  151. Willing BP, Vacharaksa A, Croxen M et al (2011) Altering host resistance to infections through microbial transplantation. PLoS ONE 6:e26988Google Scholar
  152. Wilson KH (1983) Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination. J Clin Microbiol 18:1017–1019Google Scholar
  153. Wlodarska M, Willing B, Keeney KM et al (2011) Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect Immun 79:1536–1545Google Scholar
  154. Woloj M, Tolmasky ME, Roberts MC, Crosa JH (1986) Plasmid-encoded amikacin resistance in multiresistant strains of Klebsiella pneumoniae isolated from neonates with meningitis. Antimicrob Agents Chemother 29:315–319Google Scholar
  155. Zaura E, Brandt BW, Teixeira de Mattos MJ et al (2015) Same exposure but two radically different responses to antibiotics: resilience of the salivary microbiome versus long-term microbial shifts in feces. MBio 6:e01693–15Google Scholar
  156. Zhang L, Kinkelaar D, Huang Y et al (2011) Acquired antibiotic resistance: are we born with it? Appl Environ Microbiol 77:7134–7141Google Scholar
  157. Zoch B, Karch A, Dreesman J et al (2015) Feasibility of a birth cohort study dedicated to assessing acute infections using symptom diaries and parental collection of biomaterials. BMC Infect Dis 15:436Google Scholar

Copyright information

© Springer International Publishing AG 2016

Authors and Affiliations

  1. 1.Helmholtz Centre for Infection ResearchBrunswickGermany

Personalised recommendations